Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 182.05 2.36
Ong Corp 426.85 0.20
Tata Pow 93.55 0.27
Tata Stl 537.60 0.19
Axis Ban 402.35 0.92
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Ishita Drugs & Industries Limited
Ishita Drugs & Industries Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:524400NSE:NABloomberg:ISHD@INReuters:ISHI.BO
Market Lot: 1Face Value: 10ISIN Demat: INE806D01016
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Business
Ishita Drugs & Industries (ISHITADR) was founded in 1992.The company is engaged in the manufacture of various active pharma ingredients, drug intermediates, excipients and fine chemicals. The products of the company includes Sulfacetamide, potassium iodide, nicotinamide etc. Ishita Drugs & Industries clients include companies like Pfizer, Bayer, Nicholas Piramal, Zydus Cadila Healthcare and most other leading Indian pharma companies. The compan...   More..
Future Plans
One To One
Recent news
Latest News
  -
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2013 (12)31-Mar-2012 (12)31-Mar-2011 (12)
Net sales 116.9051.9178.44
Other Income1.931.461.12
Total Income118.8353.3779.56
Cost of goods sold112.2250.9082.82
OPBDIT6.612.47-3.26
PAT4.182.083.92
Gross Block---
Equity capital29.9029.9029.90
EPS (Rs.)1.400.691.32
DPS (Rs.)---
BV (Rs.)---
P/E range (x)8.23 - 17.7932.46 - 77.907.96 - 60.95
Debt / Equity (x)---
Operating margin (% of OI) 5.6 4.6-4.1
Net margin (% of OI) 3.5 3.9 4.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
Not Available
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer